Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 17.99
+0.44 (2.51%)
Aug 10, 2026, 3:59 PM EST
Cipher Pharmaceuticals Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 447 | 384 | 354 | 133 | 96 | 46 | |
Market Cap Growth | 36.85% | 8.41% | 166.66% | 37.94% | 109.65% | 83.01% |
Enterprise Value | 438.19 | 381.06 | 386.64 | 80.46 | 57.7 | 20.59 |
Last Close Price | 17.99 | 15.06 | 14.32 | 5.53 | 3.84 | 1.77 |
PE Ratio | 10.56 | 10.45 | 21.69 | 5.22 | 2.75 | 4.83 |
Forward PE | 13.90 | 18.41 | 15.93 | 11.11 | 8.77 | 3.95 |
PS Ratio | 6.28 | 5.54 | 7.39 | 4.73 | 3.43 | 1.66 |
PB Ratio | 2.41 | 2.21 | 2.41 | 1.24 | 1.11 | 0.93 |
P/TBV Ratio | 10.59 | 10.64 | 58.80 | 2.23 | 2.17 | 2.43 |
P/FCF Ratio | 10.66 | 9.42 | 12.65 | 6.27 | 6.66 | 2.63 |
P/OCF Ratio | 10.65 | 9.41 | 12.62 | 6.26 | 6.61 | 2.63 |
EV/Sales Ratio | 6.16 | 5.50 | 8.08 | 2.87 | 2.06 | 0.74 |
EV/EBITDA Ratio | 11.63 | 11.69 | 29.45 | 5.39 | 3.53 | 1.30 |
EV/EBIT Ratio | 15.87 | 16.81 | 52.49 | 6.05 | 3.85 | 1.38 |
EV/FCF Ratio | 10.46 | 9.35 | 13.82 | 3.80 | 3.99 | 1.18 |
Debt / Equity Ratio | 0.00 | 0.04 | 0.39 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.02 | 0.23 | 4.43 | 0.03 | 0.04 | 0.04 |
Debt / FCF Ratio | 0.01 | 0.19 | 2.08 | 0.02 | 0.04 | 0.04 |
Net Debt / Equity Ratio | -0.04 | -0.02 | 0.22 | -0.49 | -0.44 | -0.51 |
Net Debt / EBITDA Ratio | -0.22 | -0.08 | 2.49 | -3.51 | -2.36 | -1.60 |
Net Debt / FCF Ratio | -0.20 | -0.07 | 1.17 | -2.47 | -2.67 | -1.45 |
Asset Turnover | 0.33 | 0.32 | 0.27 | 0.26 | 0.33 | 0.46 |
Inventory Turnover | 1.14 | 1.43 | 2.11 | 1.59 | 2.10 | 2.90 |
Quick Ratio | 0.79 | 0.75 | 1.59 | 8.55 | 3.80 | 2.21 |
Current Ratio | 1.25 | 1.12 | 1.94 | 9.19 | 4.07 | 2.39 |
Return on Equity (ROE) | 23.84% | 23.80% | 12.63% | 28.19% | 51.73% | 21.69% |
Return on Assets (ROA) | 19.53% | 16.53% | 16.14% | 20.18% | 40.89% | 17.27% |
Return on Invested Capital (ROIC) | 24.10% | 21.15% | 24.14% | 42.04% | 94.03% | 37.47% |
Return on Capital Employed (ROCE) | 14.99% | 12.05% | 4.59% | 13.82% | 21.30% | 32.04% |
Earnings Yield | 9.65% | 9.57% | 4.61% | 19.15% | 36.39% | 20.71% |
FCF Yield | 9.38% | 10.62% | 7.91% | 15.95% | 15.01% | 38.03% |
Buyback Yield / Dilution | -0.84% | -3.04% | 0.79% | 1.46% | 3.84% | 1.96% |
Total Shareholder Return | -0.84% | -3.04% | 0.79% | 1.46% | 3.84% | 1.96% |